BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8808266)

  • 1. [Epidemiologic study of the actual investigation of chronic excretors of Mycobacterium tuberculosis bacilli].
    Tsuchiya T; Kondo A; Sakatani M
    Kekkaku; 1996 Jan; 71(1):31-6. PubMed ID: 8808266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of chronic excretors of Mycobacterium bacilli in Aichi Prefecture].
    Katou M; Kakihara H
    Kekkaku; 1992 Apr; 67(4):331-46. PubMed ID: 1602726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [II. multidisciplinary analysis of chronic excretors of Mycobacterium tuberculosis bacilli].
    Kondo A; Sakatani M; Tsuchiya T; Ogata H; Fujiwara H; Hara H; Yoneda T; Sato K
    Kekkaku; 1996 Jan; 71(1):25-9. PubMed ID: 8808265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Epidemiological study on factors affecting the hospitalization period of patients with active tuberculosis].
    Fujino T; Fusegawa H; Nishiumi M; Okubo Y; Kakizaki T; Maejima K; Sugimori H
    Kekkaku; 2008 Aug; 83(8):567-72. PubMed ID: 18800648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature].
    Shishido Y; Nagayama N; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Komatsu H; Yotsumoto H
    Kekkaku; 2003 Nov; 78(11):683-9. PubMed ID: 14672045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Attributable factors to the emergence of multidrug-resistant Mycobacterium tuberculosis based on the observation of consecutive drug resistance test results].
    Fujino T; Hasegawa N; Satou R; Komatsu H; Kawada K
    Kekkaku; 1998 Jul; 73(7):471-6. PubMed ID: 9739579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A clinical study on tuberculosis among young adults in Japan: analysis on patients admitted to national hospitals in Kanto- and Kinki-areas in the year 2000].
    Yotsumoto H; Yonemaru M; Suzuki K; Kawabe Y; Sasaki Y; Toyoda E; Yamagishi F; Kudoh K; Kurasawa T; Ito M; Kawashiro T; Sakatani M; Mori M
    Kekkaku; 2003 Aug; 78(8):525-31. PubMed ID: 14509224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of drug-resistant pulmonary tuberculosis treated successfully following disappearance of rifampicin resistance after 17 years' chemotherapy].
    Shigeto E; Murakami I; Yokosaki Y
    Kekkaku; 2001 Apr; 76(4):379-83. PubMed ID: 11398329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of anti-tuberculosis drug resistance on the treatment outcome of pulmonary tuberculosis patients receiving DOTS in Riyadh, Saudi Arabia.
    Singla R; Al-Sharif N; Al-Sayegh MO; Osman MM; Shaikh MA
    Int J Tuberc Lung Dis; 2002 Jul; 6(7):585-91. PubMed ID: 12102297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A study of patient's and doctor's delay in patients with pulmonary tuberculosis discovered by visiting doctors with symptoms in particular on doctor's delay].
    Sasaki Y; Yamagishi F; Yagi T; Yamatani H; Kuroda F; Shoda H
    Kekkaku; 2000 Sep; 75(9):527-32. PubMed ID: 11068369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment outcomes of multidrug-resistant tuberculosis--comparison between success and failure cases].
    Shigetoh E; Murakami I; Yokosaki Y; Kurimoto N
    Kekkaku; 2001 Dec; 76(12):723-8. PubMed ID: 11806128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [From the views of bacteriology--focusing on drug susceptibility test].
    Ogata H
    Kekkaku; 1996 Jan; 71(1):37-41. PubMed ID: 8808267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical analysis of multidrug-resistant tuberculosis].
    Yagi T; Yamagishi F; Sasaki Y; Hamaoka T; Kuroda F; Higurashi H
    Kekkaku; 2001 Dec; 76(12):717-21. PubMed ID: 11806127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nationwide study of drug resistance among acid-fast bacilli positive pulmonary tuberculosis cases in Lebanon.
    Araj GF; Saade M; Itani LY
    Int J Tuberc Lung Dis; 2006 Jan; 10(1):63-7. PubMed ID: 16466039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A study on drug resistance of newly admitted pulmonary tuberculosis patients with special reference to the resistance to SM, INH, EB and RFP].
    Harada Y; Kitahara Y; Ninomiya H; Harada S; Takamoto M; Ishibashi T
    Kekkaku; 1994 Dec; 69(12):751-7. PubMed ID: 7844931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-resistant Mycobacterium tuberculosis in Japan: a nationwide survey, 2002.
    Tuberculosis Research Committee (Ryoken)
    Int J Tuberc Lung Dis; 2007 Oct; 11(10):1129-35. PubMed ID: 17945071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An alarming rate of drug-resistant tuberculosis at Ngwelezane Hospital in northern KwaZulu Natal, South Africa.
    Lin J; Sattar AN; Puckree T
    Int J Tuberc Lung Dis; 2004 May; 8(5):568-73. PubMed ID: 15137532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twenty-year trend of chronic excretors of tubercle bacilli based on the nationwide tuberculosis prevalence surveys in Korea, 1975-1995.
    Hong YP; Kim SJ; Bai JY; Lew WJ; Lee EG
    Int J Tuberc Lung Dis; 2000 Oct; 4(10):911-9. PubMed ID: 11055757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.